Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Oncotarget
|
November 6, 2014
Mer590, a novel monoclonal antibody targeting MER receptor tyrosine kinase, decreases colony formation and increases chemosensitivity in non-small cell lung cancer
Christopher T Cummings, Rachel M A Linger, Rebecca A Cohen, et al.
Nucleic Acids Research
|
March 23, 2024
The zinc-finger protein Z4 cooperates with condensin II to regulate somatic chromosome pairing and 3D chromatin organization
Marta Puerto, Mamta Shukla, Paula Bujosa, et al.
Journal of Medicinal Chemistry
|
July 29, 2014
UNC2025, a potent and orally bioavailable MER/FLT3 dual inhibitor
Weihe Zhang, Deborah DeRyckere, Debra Hunter, et al.
European Journal of Medicinal Chemistry
|
May 23, 2013
UNC1062, a new and potent Mer inhibitor
Jing Liu, Weihe Zhang, Michael A Stashko, et al.
Molecular Cancer Therapeutics
|
September 3, 2013
UNC569, a novel small-molecule mer inhibitor with efficacy against acute lymphoblastic leukemia in vitro and in vivo
Sandra Christoph, Deborah Deryckere, Jennifer Schlegel, et al.
Molecular Cancer Therapeutics
|
August 11, 2018
MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents
Nellie K McDaniel, Christopher T Cummings, Mari Iida, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 15, 2024
Biallelic variants in <i>POPDC2</i> cause a novel autosomal recessive syndrome presenting with cardiac conduction defects and variable hypertrophic cardiomyopathy
Michele Nicastro, Alexa M C Vermeer, Pieter G Postema, et al.
American Journal of Human Genetics
|
May 23, 2025
Bi-allelic variants in POPDC2 cause an autosomal recessive syndrome presenting with cardiac conduction defects and hypertrophic cardiomyopathy
Michele Nicastro, Alexa M C Vermeer, Pieter G Postema, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Oncotarget
|
November 6, 2014
Mer590, a novel monoclonal antibody targeting MER receptor tyrosine kinase, decreases colony formation and increases chemosensitivity in non-small cell lung cancer
Christopher T Cummings, Rachel M A Linger, Rebecca A Cohen, et al.
Nucleic Acids Research
|
March 23, 2024
The zinc-finger protein Z4 cooperates with condensin II to regulate somatic chromosome pairing and 3D chromatin organization
Marta Puerto, Mamta Shukla, Paula Bujosa, et al.
Journal of Medicinal Chemistry
|
July 29, 2014
UNC2025, a potent and orally bioavailable MER/FLT3 dual inhibitor
Weihe Zhang, Deborah DeRyckere, Debra Hunter, et al.
European Journal of Medicinal Chemistry
|
May 23, 2013
UNC1062, a new and potent Mer inhibitor
Jing Liu, Weihe Zhang, Michael A Stashko, et al.
Molecular Cancer Therapeutics
|
September 3, 2013
UNC569, a novel small-molecule mer inhibitor with efficacy against acute lymphoblastic leukemia in vitro and in vivo
Sandra Christoph, Deborah Deryckere, Jennifer Schlegel, et al.
Molecular Cancer Therapeutics
|
August 11, 2018
MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents
Nellie K McDaniel, Christopher T Cummings, Mari Iida, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 15, 2024
Biallelic variants in <i>POPDC2</i> cause a novel autosomal recessive syndrome presenting with cardiac conduction defects and variable hypertrophic cardiomyopathy
Michele Nicastro, Alexa M C Vermeer, Pieter G Postema, et al.
American Journal of Human Genetics
|
May 23, 2025
Bi-allelic variants in POPDC2 cause an autosomal recessive syndrome presenting with cardiac conduction defects and hypertrophic cardiomyopathy
Michele Nicastro, Alexa M C Vermeer, Pieter G Postema, et al.
Page
of 2